SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-073399
Filing Date
2021-05-28
Accepted
2021-05-27 17:49:12
Documents
13
Period of Report
2021-05-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2117844d1_8k.htm   iXBRL 8-K 33366
2 EXHIBIT 99.1 tm2117844d1_ex99-1.htm EX-99.1 13551
  Complete submission text file 0001104659-21-073399.txt   227717

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbh-20210526.xsd EX-101.SCH 3211
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbh-20210526_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbh-20210526_pre.xml EX-101.PRE 22728
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2117844d1_8k_htm.xml XML 3501
Mailing Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591
Business Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591 (914) 524-6800
Prestige Consumer Healthcare Inc. (Filer) CIK: 0001295947 (see all company filings)

IRS No.: 201297589 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32433 | Film No.: 21974646
SIC: 2834 Pharmaceutical Preparations